Table 3 Univariate logistic regression analysis for the prediction of MACCE in ACS patients

Age, per 1 year

0.985–1.031

Male

0.489–2.005

Body mass index, per 1 kg/m²

0.872–1.015

STE-ACS

0.474–1.456

Killip class > 1

0.520–2.037

Culprit LAD

0.579–1.666

Culprit LCx

0.169–1.411

Cilprit RCA

0.757–2.234

Multivessel disease

0.240–0.704

GRACE score > 140

0.756–2.178

Hypertension

0.492–1.429

Hypercholesterolemia

0.614–1.804

Systolic blood pressure on admission, per 1 mmHg

0.988–1.002

Heart rate on admission, per 1 bpm

0.990–1.017

Cre on admission, per 1 mg/dl

0.909–2.914

eGFR on admission, per 1%

0.982–1.008

Peak level of CPK, per 1 IU/l

0.999–1.000

BNP during stable phase, per 1 pg/ml

1.000–1.003

hs-CRP during stable phase > 0.1355 mg/dl

1.325–3.915

LDL cholesterol, per 1 mg/dl

0.993–1.007

HDL cholesterol, per 1 mg/dl

0.946–0.996

Triglycerides, per 1 mg/dl

0.997–1.001

ACE-I or ARB use at discharge

0.396–1.374

β-blocker use at discharge

0.642–1.979

Statin use at discharge

0.188–1.888

Diabetes mellitus

0.726–2.158

Impaired glucose tolerance

0.719–2.063

Normal glucose tolerance

0.242–1.074

Glucose on admission > 180 mg/dl

1.286–3.893

Hemoglobin A1c level, %

1.030–1.546

High MAGE

1.378–3.998

Ave, mg/dl

0.998–1.013

SD

0.994–1.038

CV

0.982–1.058